Smartly linked haemato-oncology: Excellence in every drop
Information
Overview
Discover how advances in laboratory diagnostics and health system reform are shaping contemporary approaches to the diagnosis and care of haematological malignancies in this three-part educational session.
Explore the use of advanced haematology analyser white pathological and precursor blood cell application 'WPC' to support earlier identification of haematological malignancies and optimise laboratory workflows. Learn about the evolving clinical role of multiparametric flow cytometry in diagnosis, classification, and monitoring, including immunophenotyping strategies and measurable residual disease (MRD) assessment. Gain a real-world perspective on haemato-oncology care, examining how national health system reforms and universal health insurance can facilitate equitable access to advanced diagnostics and sustainable care pathways, informed by Egypt’s nationwide transformation.
Join us for an insightful session highlighting how laboratory innovation and system-level change together can improve diagnostic accuracy and patient care.
Learning Objectives
- Identify haematology analyser parameters for early detection of haematological malignancies
- Explain the use of flow cytometry in haematological malignancies
- Recognise immunophenotyping and MRD assessment in disease evaluation
- Understand how combined diagnostic approaches improve patient care
- Understand how health system reforms and universal health insurance support equitable haemato-oncology care
Speakers
